Loading chat...

WV HB5482

Bill

Status

Introduced

2/12/2026

Primary Sponsor

Matthew Rohrbach

Click for details

Origin

House of Delegates

2026 Regular Session

AI Summary

  • Prohibits health insurers and pharmacy benefit managers from refusing to pay participating providers for covered clinician-administered drugs or requiring these medications to be dispensed only by plan-selected pharmacies

  • Protects patients' right to choose their provider or pharmacy for clinician-administered drugs without financial penalties, steering, or additional cost-sharing beyond standard plan amounts

  • Defines clinician-administered drugs as prescription medications that cannot reasonably be self-administered and are typically given by healthcare professionals in clinical settings such as physician offices or infusion centers

  • Allows insurers to offer, but not require, home infusion or external infusion sites, and permits specialty care centers of excellence based on objective quality measures

  • Violations constitute unfair trade practices subject to penalties under West Virginia's Unfair Trade Practices and Consumer Protection Law, and any contract provisions contrary to these rules are void and unenforceable

Legislative Description

Protecting patient access to clinician-administered medications.

Health

Last Action

To House Health and Human Resources

2/12/2026

Committee Referrals

Health & Human Resources2/12/2026

Full Bill Text

No bill text available